Displaying items by tag: medicine

Monday, 14 October 2013 11:01

CPI deadline nears for new UK biologics centre

The Centre for Process Innovation (CPI) is close to completing the first stage in its process to award the design and build contract for the new National Biologics Manufacturing Centre (NBMC).

The NBMC, to be located at Central Park, Darlington, was officially announced by the UK government last December, with the project to be managed by CPI.

The facility will be designed to assist companies in proving and scaling-up processes to manufacture new biologic medicines such as antibodies and vaccines.

The project is part of the government's Strategy for UK Life Sciences’ launched in 2011 to strengthen the life-science sector. It will support the commercialisation of research by promoting collaboration between academia, the National Health Service and industry.

The overall goal is to bridge the gap between UK research and manufacturing in biologics: increasing both the country's manufacturing capabilities and its attractiveness to inward investors.

CPI has agreed a contract for conceptual design of the NBMC – the Centre will be conceptually designed to at least RIBA Stage C. This conceptual design will be made available to shortlisted bidders.

CPI has issued PQQs (pre-qualification questionnaires) to assist it in deciding which bidders to short-list for the design and build project. The deadline for return is 16 Oct.

After evaluating the PQQs, CPI will invite tenders from qualified bidders and has listed 24 Dec as the earliest possible contract-award date.

Published in Uncategorised

Tagged under